Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
Authors
Keywords
COVID 19, Intensive care units, Cytokines, C-reactive proteins, Corticosteroid therapy, Inflammation, Sepsis, White blood cells
Journal
PLoS One
Volume 15, Issue 12, Pages e0244628
Publisher
Public Library of Science (PLoS)
Online
2021-01-01
DOI
10.1371/journal.pone.0244628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
- (2020) Fang Liu et al. JOURNAL OF CLINICAL VIROLOGY
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
- (2020) Matthijs Kox et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cytokine removal in human septic shock: Where are we and where are we going?
- (2019) Patrick M. Honore et al. Annals of Intensive Care
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
- (2013) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
- (2011) Praveen Ravishankaran et al. World Journal of Surgical Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search